Skip to main content
NCBI home page
Gut logoLink to Gut
. 1986 Aug;27(8):919–925. doi: 10.1136/gut.27.8.919

Latent pulmonary involvement in Crohn's disease: biological, functional, bronchoalveolar lavage and scintigraphic studies.

P Bonniere, B Wallaert, A Cortot, X Marchandise, Y Riou, A B Tonnel, J F Colombel, C Voisin, J C Paris
PMCID: PMC1433358  PMID: 3015749

Abstract

We have investigated the following pulmonary related parameters in 22 patients with Crohn's disease who were free of clinical pulmonary symptoms and had normal chest roentgenograms and in 25 controls: serum angiotensin converting enzyme, pulmonary function tests, bronchoalveolar lavage (lymphocyte count and subpopulations, macrophage viability and superoxide anion release by macrophages) and pulmonary scannings. Serum angiotensin converting enzyme was lower in Crohn's disease (14.1 +/- 5.1) than in controls (25.2 +/- 4.7) (p less than 0.001). Twelve of 22 Crohn's disease (54%) had a bronchoalveolar lavage lymphocytosis (greater than 18% alveolar lymphocytes). Bronchoalveolar lavage lymphocytes subpopulations were quite variable. Twelve of 17 Crohn's disease (71%) had an increase spontaneous and/or stimulated superoxide anion production by alveolar macrophages. Six of 12 Crohn's disease (50%) had an increase physiologic dead space in the upper part of their lung against one of 11 controls (9%). These data suggest that most patients with Crohn's disease have a latent pulmonary involvement.

Full text

PDF
919

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aerts C., Wallaert B., Grosbois J. M., Voisin C. Release of superoxide anion by alveolar macrophages in pulmonary sarcoidosis. Ann N Y Acad Sci. 1986;465:193–200. doi: 10.1111/j.1749-6632.1986.tb18495.x. [DOI] [PubMed] [Google Scholar]
  2. BRYAN A. C., BENTIVOGLIO L. G., BEEREL F., MACLEISH H., ZIDULKA A., BATES D. V. FACTORS AFFECTING REGIONAL DISTRIBUTION OF VENTILATION AND PERFUSION IN THE LUNG. J Appl Physiol. 1964 May;19:395–402. doi: 10.1152/jappl.1964.19.3.395. [DOI] [PubMed] [Google Scholar]
  3. Berliner S., Neeman A., Shoenfeld Y., Eldar M., Rousso I., Kadish U., Pinkhas J. Salazopyrin-induced eosinophilic pneumonia. Respiration. 1980;39(2):119–120. doi: 10.1159/000194205. [DOI] [PubMed] [Google Scholar]
  4. Best W. R., Becktel J. M., Singleton J. W. Rederived values of the eight coefficients of the Crohn's Disease Activity Index (CDAI). Gastroenterology. 1979 Oct;77(4 Pt 2):843–846. [PubMed] [Google Scholar]
  5. Butland R. J., Cole P., Citron K. M., Turner-Warwick M. Chronic bronchial suppuration and inflammatory bowel disease. Q J Med. 1981;50(197):63–75. [PubMed] [Google Scholar]
  6. Constantinidis K. A. Letter: Eosinophilic pneumonia: an unusual side effect of therapy with salicylazosulfapyridine. Chest. 1976 Aug;70(2):315–316. doi: 10.1378/chest.70.2.315. [DOI] [PubMed] [Google Scholar]
  7. Crystal R. G., Bitterman P. B., Rennard S. I., Hance A. J., Keogh B. A. Interstitial lung diseases of unknown cause. Disorders characterized by chronic inflammation of the lower respiratory tract (first of two parts). N Engl J Med. 1984 Jan 19;310(3):154–166. doi: 10.1056/NEJM198401193100304. [DOI] [PubMed] [Google Scholar]
  8. Davies D., MacFarlane A. Fibrosing alveolitis and treatment with sulphasalazine. Gut. 1974 Mar;15(3):185–188. doi: 10.1136/gut.15.3.185. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Dinakara P., Blumenthal W. S., Johnston R. F., Kauffman L. A., Solnick P. B. The effect of anemia on pulmonary diffusing capacity with derivation of a correction equation. Am Rev Respir Dis. 1970 Dec;102(6):965–969. doi: 10.1164/arrd.1970.102.6.965. [DOI] [PubMed] [Google Scholar]
  10. Eade O. E., Smith C. L., Alexander J. R., Whorwell P. J. Pulmonary function in patients with inflammatory bowel disease. Am J Gastroenterol. 1980 Feb;73(2):154–156. [PubMed] [Google Scholar]
  11. Forrest J. A., Shearman D. J. Pulmonary vasculitis and ulcerative colitis. Am J Dig Dis. 1975 May;20(5):482–486. doi: 10.1007/BF01070795. [DOI] [PubMed] [Google Scholar]
  12. Ganguly N. K., Kingham J. G., Lloyd B., Lloyd R. S., Price C. P., Triger D. R., Wright R. Acid hydrolases in monocytes from patients with inflammatory bowel disease, chronic liver disease, and rheumatoid arthritis. Lancet. 1978 May 20;1(8073):1073–1075. doi: 10.1016/s0140-6736(78)90917-0. [DOI] [PubMed] [Google Scholar]
  13. Heatley R. V., Thomas P., Prokipchuk E. J., Gauldie J., Sieniewicz D. J., Bienenstock J. Pulmonary function abnormalities in patients with inflammatory bowel disease. Q J Med. 1982 Summer;51(203):241–250. [PubMed] [Google Scholar]
  14. Henrion F., Bretagne M. C., Neimann L., Flechon P. E., Canton P., Hoeffel J. C. Association exceptionnelle de lésions pulmonaires, cutanées et d'une iléite terminale chez un enfant de 11 ans. J Radiol. 1982 Feb;63(2):123–126. [PubMed] [Google Scholar]
  15. Higenbottam T., Cochrane G. M., Clark T. J., Turner D., Millis R., Seymour W. Bronchial disease in ulcerative colitis. Thorax. 1980 Aug;35(8):581–585. doi: 10.1136/thx.35.8.581. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Isenberg J. I., Goldstein H., Korn A. R., Ozeran R. S., Rosen V. Pulmonary vasculitis--an uncommon complication of ulcerative colitis. Report of a case. N Engl J Med. 1968 Dec 19;279(25):1376–1377. doi: 10.1056/NEJM196812192792506. [DOI] [PubMed] [Google Scholar]
  17. Johnson N. M., Mee A. S., Jewell D. P., Clarke S. W. Pulmonary function in inflammatory bowel disease. Digestion. 1978;18(5-6):416–418. doi: 10.1159/000198228. [DOI] [PubMed] [Google Scholar]
  18. Jones G. R., Malone D. N. Sulphasalazine induced lung disease. Thorax. 1972 Nov;27(6):713–717. doi: 10.1136/thx.27.6.713. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Kraft S. C., Earle R. H., Roesler M., Esterly J. R. Unexplained bronchopulmonary disease with inflammatory bowel disease. Arch Intern Med. 1976 Apr;136(4):454–459. [PubMed] [Google Scholar]
  20. Lieberman J. Elevation of serum angiotensin-converting-enzyme (ACE) level in sarcoidosis. Am J Med. 1975 Sep;59(3):365–372. doi: 10.1016/0002-9343(75)90395-2. [DOI] [PubMed] [Google Scholar]
  21. McKee A. L., Rajapaksa A., Kalish P. E., Pitchumoni C. S. Severe interstitial pulmonary fibrosis in a patient with chronic ulcerative colitis. Am J Gastroenterol. 1983 Feb;78(2):86–89. [PubMed] [Google Scholar]
  22. Meadway J. Ulcerative colitis, colitic spondylitis and associated apical pulmonary fibrosis. Proc R Soc Med. 1974 May;67(5):324–325. [PMC free article] [PubMed] [Google Scholar]
  23. Mee A. S., Jewell D. P. Monocytes in inflammatory bowel disease: monocyte and serum lysosomal enzyme activity. Clin Sci (Lond) 1980 Apr;58(4):295–300. doi: 10.1042/cs0580295. [DOI] [PubMed] [Google Scholar]
  24. Pasquis P., Colin R., Denis P., Baptiste P., Galmiche J. P., Hecketsweiler P. Transient pulmonary impairment during attacks of Crohn's disease. Respiration. 1981;41(1):56–59. doi: 10.1159/000194359. [DOI] [PubMed] [Google Scholar]
  25. Rankin G. B., Watts H. D., Melnyk C. S., Kelley M. L., Jr National Cooperative Crohn's Disease Study: extraintestinal manifestations and perianal complications. Gastroenterology. 1979 Oct;77(4 Pt 2):914–920. [PubMed] [Google Scholar]
  26. Rogers B. H., Clark L. M., Kirsner J. B. The epidemiologic and demographic characteristics of inflammatory bowel disease: an analysis of a computerized file of 1400 patients. J Chronic Dis. 1971 Dec;24(12):743–773. doi: 10.1016/0021-9681(71)90087-7. [DOI] [PubMed] [Google Scholar]
  27. Shah S. M., Texter E. C., Jr, White H. J. Inflammatory bowel disease associated with granulomatous lung disease: report of a case with endoscopic findings. Gastrointest Endosc. 1976 Nov;23(2):98–99. doi: 10.1016/s0016-5107(76)73607-1. [DOI] [PubMed] [Google Scholar]
  28. Thomas P., Seaton A., Edwards J. Respiratory disease due to sulphasalazine. Clin Allergy. 1974 Mar;4(1):41–47. doi: 10.1111/j.1365-2222.1974.tb01361.x. [DOI] [PubMed] [Google Scholar]
  29. Tydd T. F. Sulphasalazine lung. Med J Aust. 1976 Apr 17;1(16):570–573. [PubMed] [Google Scholar]
  30. Wallaert B., Aerts C., Bonniere P., Cortot A., Tonnel A. B., Paris J. C., Voisin C. Superoxide anion generation by alveolar macrophages in Crohn's disease. N Engl J Med. 1985 Feb 14;312(7):444–445. doi: 10.1056/NEJM198502143120715. [DOI] [PubMed] [Google Scholar]
  31. Wallaert B., Colombel J. F., Tonnel A. B., Bonniere P., Cortot A., Paris J. C., Voisin C. Evidence of lymphocyte alveolitis in Crohn's disease. Chest. 1985 Mar;87(3):363–367. doi: 10.1378/chest.87.3.363. [DOI] [PubMed] [Google Scholar]
  32. Williams T., Eidus L., Thomas P. Fibrosing alveolitis, bronchiolitis obliterans, and sulfasalazine therapy. Chest. 1982 Jun;81(6):766–768. doi: 10.1378/chest.81.6.766. [DOI] [PubMed] [Google Scholar]
  33. Yaffe B. H., Korelitz B. I. Sulfasalazine pneumonitis. Am J Gastroenterol. 1983 Aug;78(8):493–494. [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES